NEW YORK--(BUSINESS WIRE)--Jul 18, 2023--ENB Therapeutics, Inc., a biotechnology company pioneering a new and differentiated class of therapeutics targeting the endothelin B receptor (ETBR) inhibitor, today announced that the company has completed enrollment of its international Phase 1 ...
BOSTON--(BUSINESS WIRE)--Jul 18, 2023--<a ...
PLYMOUTH MEETING, Pa.--(BUSINESS WIRE)--Jul 18, 2023--AdaptHealth Corp. (NASDAQ: AHCO) (鈥淎daptHealth鈥� or the 鈥淐ompany鈥�), a national leader in providing patient-centered, healthcare-at-home solutions including home medical equipment, medical supplies, and related services, will release ...
SAN DIEGO--(BUSINESS WIRE)--Jul 18, 2023--Engrail Therapeutics鈩� (Engrail) (the Company), a precision neuroscience company focused on the acquisition, development, and commercialization of transformational therapies, today announced initiation of a multi-center phase 2 clinical trial, the ...
IRVINE, Calif.--(BUSINESS WIRE)--Jul 18, 2023--<a ...
DUBLIN--(BUSINESS WIRE)--Jul 18, 2023--The <a ...